FDA Reconsidering Medstone STS Lithotripter PMA For Gallstone Treatment
This article was originally published in The Gray Sheet
Executive Summary
Medstone International is developing a protocol for a post-approval clinical study of the firm's STS lithotripter for gallstone treatment as FDA begins to revisit its August 1998 decision to reject the firm's premarket approval application.